The molecular basis of the earliest neuronal changes that lead to Alzheimer’s disease (AD) is unclear. Here, we analyze neural cells derived from sporadic AD (SAD), APOE4 gene-edited and control induced pluripotent stem cells (iPSCs). We observe major differences in iPSC-derived neural progenitor (NP) cells and neurons in gene networks related to neuronal differentiation, neurogenesis, and synaptic transmission. The iPSC-derived neural cells from SAD patients exhibit accelerated neural differentiation and reduced progenitor cell renewal. Moreover, a similar phenotype appears in NP cells and cerebral organoids derived from APOE4 iPSCs. Impaired function of the transcriptional repressor REST is strongly implicated in the altered transcriptome...
Summary: Early-onset Alzheimer disease (AD)-like pathology in Down syndrome is commonly attributed t...
Selective neurodegeneration is a critical causal factor in Alzheimer's disease (AD); however, the me...
Abstract A major challenge to our understanding of the molecular mechanisms of Alzheimer’s disease (...
Summary: The molecular basis of the earliest neuronal changes that lead to Alzheimer’s disease (AD) ...
Alzheimer’s disease (AD) is a progressive, neurodegenerative disorder and it is the most common cau...
Background: Alzheimer ’ s disease (AD) is a complex, irreversible neurodegenerative disorder. At pre...
Abstract Background Many neurodegenerative disease...
Human pluripotent stem cells (PSCs) provide a unique entry to study species-specific aspects of huma...
Human pluripotent stem cells (PSCs) provide a unique entry to study species-specific aspects of huma...
The apolipoprotein E4 (APOE4) variant is the single greatest genetic risk factor for sporadic Alzhei...
Alzheimer’s disease is a devastating neurodegenerative disorder with no cure. Countless promising th...
Presenilin 1 (PSEN1) encodes the catalytic subunit of c-secretase, and PSEN1 mutations are the most ...
The apolipoprotein E4 (APOE4) variant is the single greatest genetic risk factor for sporadic Alzhei...
Background: Alzheimer’s disease (AD) is the most common type of dementia, affecting one in eight adu...
Experimental evidence has demonstrated that several aspects of adult neural stem cells (NSCs), inclu...
Summary: Early-onset Alzheimer disease (AD)-like pathology in Down syndrome is commonly attributed t...
Selective neurodegeneration is a critical causal factor in Alzheimer's disease (AD); however, the me...
Abstract A major challenge to our understanding of the molecular mechanisms of Alzheimer’s disease (...
Summary: The molecular basis of the earliest neuronal changes that lead to Alzheimer’s disease (AD) ...
Alzheimer’s disease (AD) is a progressive, neurodegenerative disorder and it is the most common cau...
Background: Alzheimer ’ s disease (AD) is a complex, irreversible neurodegenerative disorder. At pre...
Abstract Background Many neurodegenerative disease...
Human pluripotent stem cells (PSCs) provide a unique entry to study species-specific aspects of huma...
Human pluripotent stem cells (PSCs) provide a unique entry to study species-specific aspects of huma...
The apolipoprotein E4 (APOE4) variant is the single greatest genetic risk factor for sporadic Alzhei...
Alzheimer’s disease is a devastating neurodegenerative disorder with no cure. Countless promising th...
Presenilin 1 (PSEN1) encodes the catalytic subunit of c-secretase, and PSEN1 mutations are the most ...
The apolipoprotein E4 (APOE4) variant is the single greatest genetic risk factor for sporadic Alzhei...
Background: Alzheimer’s disease (AD) is the most common type of dementia, affecting one in eight adu...
Experimental evidence has demonstrated that several aspects of adult neural stem cells (NSCs), inclu...
Summary: Early-onset Alzheimer disease (AD)-like pathology in Down syndrome is commonly attributed t...
Selective neurodegeneration is a critical causal factor in Alzheimer's disease (AD); however, the me...
Abstract A major challenge to our understanding of the molecular mechanisms of Alzheimer’s disease (...